Collegium Pharmaceutical is committed to becoming the leader in responsible pain management. Our portfolio compels us to step into the pain market at a time when others have opted to step out. We recognize the importance of earning the trust of key stakeholders every day. We will continue to work hard to position Collegium to usher in a next generation of non-opioid pain solutions in the US market. We remain focused on making a positive difference in the lives of people suffering from pain and our communities.
The Sr. Director, PVG will be responsible for building, developing, and leading a Pharmacovigilance department for the evolving needs of Collegium. They will report to the Chief Medical Officer.